Regents of the University of California’s Nurix Therapeutics NRIX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-204,123	Closed	-$2.86M	–	41
2022 Q1	$2.86M	Hold	204,123	–	–	0.43%	12
2021 Q4	$5.91M	Sell	204,123 -367,089	-64%	-$10.6M	0.83%	11
2021 Q3	$17.1M	Hold	571,212	–	–	2.02%	7
2021 Q2	$15.2M	Buy	+571,212	New	+$15.2M	1.93%	8